TNB Tech Minute: OpenAI Publishes New AI Policy Proposals

Plus: federal regulators close investigation into Tesla’s autonomous summon feature. And Neurocrine Biosciences agrees to acquire Soleno Therapeutics for $2.9 billion. Danny Lewis hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices